Prosecution Insights
Last updated: October 27, 2026

Carering Technologies Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Carering Technologies Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. This indicates a focused technical scope for the company's current patent prosecution. The concentration of the 1 pending office action within a single art unit suggests that the innovation being pursued is specialized within the biotechnology or pharmaceutical fields.

YU, HONG is the busiest examiner for this portfolio, managing 1 pending office action. With only 1 distinct examiner and 1 pending office action, this examiner is responsible for all current activity. The 1 distinct art unit confirms the concentrated nature of the pending pharmaceutical or biotechnological matter. For the company, this means that the outcome of its current active prosecution is entirely dependent on the evaluation of this single examiner within their specific art unit, requiring a focused response to any office actions raised during the process.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YU, HONG 1 31.1% +5.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18576605 ORTHODONTIC SEPARATOR YU, HONG —

Top Art Units

Art UnitApps
1614 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18576605 ORTHODONTIC SEPARATOR YU, HONG 1614 §102§103§112 Final Rejection — Pending Jan 04, 2024

Managing Carering Technologies Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Carering Technologies Ltd. have?

Carering Technologies Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Carering Technologies Ltd. applications?

Hong Yu has the most, with 1 of Carering Technologies Ltd.'s pending office actions.

What technology area are Carering Technologies Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month